Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Pragmatic Framework for Addressing Challenges and Mitigating Bias in Radiology Residency Selection: An Academic Residency Program's Experience.

Academic radiology·2025
Same author

Evaluating a Rapid Immunity Test to Predict Dairy Calf Mortality Risk.

Biology·2025
Same author

Rapid Isolation and Characterization of Exosomes through a Single-Step, Label-Free Protein Biomarker Analysis.

ACS applied bio materials·2025
Same author

Associations of Frailty, Concerns About Falling, and Fall Risk in Community-Dwelling Older Adults in Orlando, Florida: A Preliminary Analysis.

Journal of frailty, sarcopenia and falls·2025
Same author

Doxycycline versus cephalexin treatment of presumed streptococcal skin and soft tissue infection among adults presenting to the emergency department.

Antimicrobial agents and chemotherapy·2024
Same author

Assessment of a behavioral health emergency response diversion (BHERD) program.

The American journal of emergency medicine·2023

Related Experiment Video

Updated: May 24, 2026

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
07:54

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Published on: March 25, 2019

Developing a nanoparticle test for prostate cancer scoring.

Qun Huo1, Sally A Litherland, Shannon Sullivan

  • 1NanoScience Technology Center and Department of Chemistry, University of Central Florida, 12424 Research Parkway, Orlando, FL 32826, USA. Qun.Huo@ucf.edu

Journal of Translational Medicine
|March 13, 2012
PubMed
Summary
This summary is machine-generated.

A new nanoparticle test quantitatively measures prostate cancer aggressiveness, distinguishing tumors and aiding treatment decisions. This molecular biomarker test offers a potential alternative to subjective Gleason scores for improved prostate cancer management.

More Related Videos

Standardized SDS-PAGE Workflow for Personalized Protein Corona Profiling in Early Cancer Detection
10:02

Standardized SDS-PAGE Workflow for Personalized Protein Corona Profiling in Early Cancer Detection

Published on: December 19, 2025

Nanosensors to Detect Protease Activity In Vivo for Noninvasive Diagnostics
10:50

Nanosensors to Detect Protease Activity In Vivo for Noninvasive Diagnostics

Published on: July 16, 2018

Related Experiment Videos

Last Updated: May 24, 2026

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
07:54

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Published on: March 25, 2019

Standardized SDS-PAGE Workflow for Personalized Protein Corona Profiling in Early Cancer Detection
10:02

Standardized SDS-PAGE Workflow for Personalized Protein Corona Profiling in Early Cancer Detection

Published on: December 19, 2025

Nanosensors to Detect Protease Activity In Vivo for Noninvasive Diagnostics
10:50

Nanosensors to Detect Protease Activity In Vivo for Noninvasive Diagnostics

Published on: July 16, 2018

Area of Science:

  • Nanotechnology
  • Biomolecular diagnostics
  • Prostate cancer research

Background:

  • Over-diagnosis and treatment of prostate cancer is a significant issue.
  • Gleason score, the primary prognostic factor, is subjective and qualitative.
  • Limited molecular biomarkers exist for predicting prostate tumor aggressiveness.

Purpose of the Study:

  • To develop a nanoparticle-based test for prostate cancer diagnosis and quantitative aggressiveness prediction.
  • To investigate the interaction between tumor-specific molecules and protein corona on gold nanoparticles.

Main Methods:

  • A prostate tissue lysate was spiked into serum/IgG solution and incubated with gold nanoparticles.
  • Changes in nanoparticle size due to tumor-specific molecule interactions were measured using dynamic light scattering.
  • Statistical analysis included ANOVA and t-tests/Mann-Whitney U-tests.

Main Results:

  • An inverse correlation was found between nanoparticle size and prostate tumor aggressiveness.
  • Smaller nanoparticle sizes indicated higher tumor grade, with significant differences observed.
  • The test showed potential for differentiating intermediate-grade tumors.

Conclusions:

  • A novel nanoparticle test offers a quantitative measure of prostate cancer aggressiveness.
  • This test could complement Gleason score pathology for better clinical decision-making.
  • Further validation in larger patient cohorts is needed to establish its diagnostic utility.